Toward in vivo histology: A comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2 ⁎-imaging at ultra-high magnetic field strength


Journal article


A. Deistung, A. Schäfer, F. Schweser, Uta Biedermann, R. Turner, J. Reichenbach
NeuroImage, 2013

Semantic Scholar DBLP DOI PubMed
Cite

Cite

APA
Deistung, A., Schäfer, A., Schweser, F., Biedermann, U., Turner, R., & Reichenbach, J. (2013). Toward in vivo histology: A comparison of quantitative susceptibility mapping (QSM) with magnitude-, phase-, and R2 ⁎-imaging at ultra-high magnetic field strength. NeuroImage.

Chicago/Turabian
Deistung, A., A. Schäfer, F. Schweser, Uta Biedermann, R. Turner, and J. Reichenbach. “Toward in Vivo Histology: A Comparison of Quantitative Susceptibility Mapping (QSM) with Magnitude-, Phase-, and R2 ⁎-Imaging at Ultra-High Magnetic Field Strength.” NeuroImage (2013).

MLA
Deistung, A., et al. “Toward in Vivo Histology: A Comparison of Quantitative Susceptibility Mapping (QSM) with Magnitude-, Phase-, and R2 ⁎-Imaging at Ultra-High Magnetic Field Strength.” NeuroImage, 2013.